Last updated on April 2018

EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Osteoarticular Infection
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Adult patients (over 18 years old) who gave their signed inform consent,
  • Who present an osteo-articular infection with susceptible Staphylococcus spp.,
  • To whom a rifampicin based regimen is prescribed, in association with another antibiotic, for at least 14 days,
  • Patients covered by Health Insurance.

Exclusion Criteria:

  • Patients weighing less than 45 kg or more than 150 kg,
  • Patients with active TB (whatever its localization),
  • Presence or anticipated need during the study period, of drugs contraindicated with rifampicin: anticalcineurins, protease inhibitors and nevirapine,
  • Patients with a known and documented rifampicin allergy.
  • Pregnant or breastfeeding woman,
  • Adults legally protected (under judicial protection, guardianship or supervision), persons deprived of their liberty,
  • Patients participating in another interventional clinical trial (biomedical trial or standard care clinical trial).

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.